Table 1. Demographic characteristics of participants.
| Antigen RDT | BIOCREDIT COVID -19 Ag | COVID-19 Ag Respi-Strip | PCL COVID19 Ag Rapid FIA | MEDsan® SARS-CoV-2 Antigen Rapid test | Panbio™ COVID-19 Ag Rapid test | Novegent COVID-19 Antigen Rapid test kit (colloidal gold) | VivaDiag™ SARS-CoV-2 Ag Rapid Test kit |
|---|---|---|---|---|---|---|---|
| N | 247 | 194 | 172 | 243 | 185 | 229 | 263 |
| Sex | |||||||
| M | 165 (66.8) | 156 (80.4) | 142(82.6) | 156 (64.2) | 136(73.5) | 132(57.6) | 137 (52.1) |
| F | 76 (30.8) | 38 (19.6) | 30 (17.4) | 77 (31.7) | 49(26.5) | 97(42.4) | 126 (47.9) |
| Missing | 6 (2.4) | 10 (4.1) | |||||
| Age in years | |||||||
| <20 | 2(0.8) | 4(2.1) | 3(1.7) | 5(2.1) | 6(3.2) | 1(0.4) | 4(1.5) |
| 20–29 | 68(27.5) | 54(27.8) | 49(28.5) | 39(16.0) | 53(28.7) | 28(12.2) | 77(29.3) |
| 30–39 | 87(35.2) | 62(32.0) | 48(27.9) | 39(16.0) | 59(31.9) | 52(22.7) | 66(25.1) |
| 40–49 | 29(11.8) | 34(17.5) | 22(12.8) | 36(14.8) | 33(17.8) | 46(20.1) | 41(15.6) |
| 50 and above | 61(24.7) | 17(8.8) | 50(29.1) | 41(16.9) | 34(18.4) | 97(42.4) | 71(27.0) |
| Missing | 23(11.9) | 83(34.2) | 5 (2.2) | 4 (1.5) | |||
| Duration of symptoms | |||||||
| 0–7 Days | 97(39.3) | No information | 32(18.6) | 68(28.0) | 117(63.2) | 137(59.8) | 235(89.4) |
| >7 Days | 42(17.0) | 11(6.4) | 49(20.2) | 20(10.8) | 88(38.4) | 21(8.0) | |
| No symptoms/missing | 108(43.7) | 129(75.0) | 126(51.9) | 48(26.0) | 4(1.8) | 7(2.7) | |
| PCR (Berlin protocol) | |||||||
| Positive | 135 (54.7) | 67 (34.5) | 93 (54.1) | 123 (50.6) | 85 (46.0) | 100(43.7) | 43 (16.4) |
| Negative | 112 (45.3) | 127 (65.5) | 79 (45.9) | 120 (49.4) | 100(54.1) | 129(56.3) | 220 (83.6) |